Insulin glargine 100 UNT/ML / lixisenatide 33 mcg/ML in 3 mL Pen Injector
RxNorm 1858995
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1858995 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: insulin glargine 100 UNT/ML / lixisenatide 33 mcg/ML in 3 mL Pen Injector.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
3 mL insulin glargine 100 UNT/ML / lixisenatide 0.033 mg/ML Pen Injector
(Atom ID: 12350068)
PSNPrescribable
Prescribable Name (PSN):
Insulin glargine 100 UNT/ML / lixisenatide 33 mcg/ML in 3 mL Pen Injector
(Atom ID: 8698936)
SYPrescribable